Vanguard Group Inc Bio Rad Laboratories, Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,912,157 shares of BIO stock, worth $438 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,912,157
Previous 1,919,808
0.4%
Holding current value
$438 Million
Previous $631 Million
26.15%
% of portfolio
0.01%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding BIO
# of Institutions
462Shares Held
18.9MCall Options Held
12.7KPut Options Held
14.4K-
First Eagle Investment Management, LLC1.57MShares$359 Million0.8% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$355 Million0.01% of portfolio
-
Veritas Asset Management LLP913KShares$209 Million2.52% of portfolio
-
Dimensional Fund Advisors LP Austin, TX877KShares$201 Million0.05% of portfolio
-
Ariel Investments, LLC Chicago, IL725KShares$166 Million2.29% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $5.64B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...